DD Support Board and Research Team

[nodummy]

ALZM - That toxic financing agreement with Centurion Private Equity, LLC means nothing unless ALZM files an S-1 and gets the S-1 approved by the SEC.

So far ALZM has not filed an S-1 to register the shares to sell in that toxic financing agreement.

Anybody that is truly long on ALZM better hope that ALZM never does the S-1 filing because if they do end up following through with filing the S-1 and it does get approved, Centurion will get to dilute discounted free trading shares into the market killing the share price and since Jan and Hipple (Healthcare of Today) have it written into their agreement with ALZM that they will always get to own 60% of the outstanding shares that means that for every share Centurion would get issued at a discount to dump into the market, Jan and Hipple will get a share also causing the outstanding share count to grow twice as fast.

ALZM already has toxic debt Notes out with Asher Enterprises Inc and Crystal Falls Investments, LLC. ALZM already has $2,326,940 in debt Notes total - $499,072 of which is past due. A good portion of those debt Notes will get to convert into common shares at less than half of the market price. Some may get converted during this recent pump&dump. Bottom line is that the ALZM share price has a lot going against it in the future.

Revenues since inception - $0
Losses since inception - $28,096,219

Names involved - Henry Jan, Robert Hipple, Michael J. Gelmon